Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open Respiratory Research"
DOI: 10.1136/bmjresp-2021-001139
Abstract: Objective Research is needed to determine best practice for genomic testing in the context of child interstitial or diffuse lung disease (chILD). We explored parent’s and child’s health-related quality of life (HRQoL), parents’ perceived understanding… read more here.
Keywords: genomic testing; diffuse lung; interstitial diffuse; lung disease ... See more keywords
Pulmonary Aptamer Signatures in Children's Interstitial and Diffuse Lung Diseases.
Sign Up to like & getrecommendations! Published in 2019 at "American journal of respiratory and critical care medicine"
DOI: 10.1164/rccm.201903-0547oc
Abstract: RATIONALE Biomarker signatures are needed in children with interstitial and diffuse lung disease (chILD) to improve diagnostic approaches, increase our understanding of disease pathogenesis, monitor disease progression, and develop new treatment strategies. Proteomic technology using… read more here.
Keywords: pulmonary aptamer; children interstitial; interstitial diffuse; diffuse lung ... See more keywords